EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjögren's syndrome
暂无分享,去创建一个
P. Ravaud | X. Mariette | E. Theander | S. Bombardieri | J. Gottenberg | V. Devauchelle | A. Saraux | T. Dörner | E. Hachulla | H. Bootsma | R. Seror | C. Vitali | S. Bowman | M. Tomšič | T. Mandl | A. Tzioufas | A. Hansen | M. Ramos-Casals | J. Brun | A. Kruize | S. Praprotnik | S. Devita | C. Vollenweider | S. Carsons | N. Sutcliffe | S. Bowman
[1] A. Vissink,et al. Effectiveness of rituximab treatment in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled trial. , 2010, Arthritis and rheumatism.
[2] G. Baron,et al. EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome , 2009, Annals of the rheumatic diseases.
[3] R. Barry,et al. Patient-reported outcomes in primary Sjogren's syndrome: comparison of the long and short versions of the Profile of Fatigue and Discomfort--Sicca Symptoms Inventory. , 2008, Rheumatology.
[4] R. Barry,et al. The Sjögren's Syndrome Damage Index--a damage index for use in clinical trials and observational studies in primary Sjögren's syndrome. , 2008, Rheumatology.
[5] D A Isenberg,et al. Sjögren's Systemic Clinical Activity Index (SCAI)--a systemic disease activity measure for use in clinical trials in primary Sjögren's syndrome. , 2007, Rheumatology.
[6] S. Bombardieri,et al. Sjögren's Syndrome Disease Damage Index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome, derived from an analysis of a cohort of Italian patients. , 2007, Arthritis and rheumatism.
[7] A. Vissink,et al. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study. , 2005, Arthritis and rheumatism.
[8] S. Bowman,et al. Measurement of fatigue and discomfort in primary Sjogren's syndrome using a new questionnaire tool. , 2004, Rheumatology.
[9] S. Bowman,et al. Validation of the Sicca Symptoms Inventory for clinical studies of Sjögren's syndrome. , 2003, The Journal of rheumatology.
[10] R. Jonsson,et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group , 2002, Annals of the rheumatic diseases.
[11] Stanley B. Cohen,et al. A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca. , 2002, Arthritis and rheumatism.
[12] R. Jonsson,et al. Revisiting Sjögren's syndrome in the new millennium: perspectives on assessment and outcome measures. Report of a workshop held on 23 March 2000 at Oxford, UK. , 2001, Rheumatology.
[13] S. Bowman,et al. Outcome measures in Sjögren's syndrome. , 2001, Rheumatology.
[14] P. Fox,et al. Clinical course of primary Sjögren's syndrome: salivary, oral, and serologic aspects. , 2000, The Journal of rheumatology.
[15] I. Griffiths,et al. Primary Sjögren's syndrome in the North East of England: a long-term follow-up study. , 1999, Rheumatology.
[16] F. Vivino,et al. Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group. , 1999, Archives of internal medicine.
[17] A. Silman,et al. Weak association between subjective symptoms of and objective testing for dry eyes and dry mouth: results from a population based study , 1998, Annals of the rheumatic diseases.
[18] A. Vissink,et al. Rituximab treatment in primary Sjogren's syndrome , 2005 .
[19] S. Pillemer,et al. Outcome measures for Sjögren's syndrome, April 10-11, 2003, Bethesda, Maryland, USA. , 2005, The Journal of rheumatology.
[20] R. Jonsson,et al. Current concepts on diagnosis, autoantibodies and therapy in Sjögren's syndrome. , 2000, Scandinavian journal of rheumatology.
[21] M. Prevoo,et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. , 1995, Arthritis and rheumatism.